Jentashapir Journal of Health Research

Published by: Kowsar
Crossmark

Prevalence of Colorectal Cancers in Isfahan Province, Iran

Zahra Tolou-Ghamari ORCID 1 , *
Author Information
1 Isfahan Kidney Transplanation Research Center, Alzahra Research Centers, Isfahan University of Medical Sciences, Isfahan, Iran
Article information
  • Jentashapir Journal of Health Research: April 30, 2019, 10 (2); e92128
  • Published Online: July 22, 2019
  • Article Type: Research Article
  • Received: April 10, 2019
  • Accepted: June 23, 2019
  • DOI: 10.5812/jjhr.92128

How to Cite: Tolou-Ghamari Z. Prevalence of Colorectal Cancers in Isfahan Province, Iran, Jentashapir J Health Res. 2019 ; 10(2):e92128. doi: 10.5812/jjhr.92128.

Abstract
Copyright © 2025, Jentashapir Journal of Health Research. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Marley AR, Nan H. Epidemiology of colorectal cancer. Int J Mol Epidemiol Genet. 2016;7(3):105-14. [PubMed: 27766137]. [PubMed Central: PMC5069274].
  • 2. Melnitchouk N, Shabat G, Lu P, Lyu H, Scully R, Leung K, et al. Colorectal cancer in ukraine: Regional disparities and national trends in incidence, management, and mortality. J Glob Oncol. 2018;4:1-8. doi: 10.1200/JGO.18.00145. [PubMed: 30354936].
  • 3. Bosman FT. Colorectal cancer. In: Stewart BW, Wild CP, editors. World cancer report, the international agency for research on cancer. World Health Organization; 2014.
  • 4. Haggar FA, Boushey RP. Colorectal cancer epidemiology: Incidence, mortality, survival, and risk factors. Clin Colon Rectal Surg. 2009;22(4):191-7. doi: 10.1055/s-0029-1242458. [PubMed: 21037809]. [PubMed Central: PMC2796096].
  • 5. Janout V, Kollarova H. Epidemiology of colorectal cancer. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2001;145(1):5-10. doi: 10.5507/bp.2001.001. [PubMed: 12415635].
  • 6. [No author listed] . 6 cancer of the colon and rectum (invasive) 5-year relative and period survival by race, sex, diagnosis year, age and stage at diagnosis. Seer Cancer Government; 17 May 2016.
  • 7. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87-108. doi: 10.3322/caac.21262. [PubMed: 25651787].
  • 8. Khuhaprema T, Srivatanakul P. Colon and rectum cancer in Thailand: An overview. Jpn J Clin Oncol. 2008;38(4):237-43. doi: 10.1093/jjco/hyn020. [PubMed: 18356191].
  • 9. Dolatkhah R, Somi MH, Bonyadi MJ, Asvadi Kermani I, Farassati F, Dastgiri S. Colorectal cancer in Iran: Molecular epidemiology and screening strategies. J Cancer Epidemiol. 2015;2015:643020. doi: 10.1155/2015/643020. [PubMed: 25685149]. [PubMed Central: PMC4312646].
  • 10. Ibrahim EM, Zeeneldin AA, El-Khodary TR, Al-Gahmi AM, Bin Sadiq BM. Past, present and future of colorectal cancer in the Kingdom of Saudi Arabia. Saudi J Gastroenterol. 2008;14(4):178-82. doi: 10.4103/1319-3767.43275. [PubMed: 19568534]. [PubMed Central: PMC2702938].
  • 11. Jemal A, Clegg LX, Ward E, Ries LA, Wu X, Jamison PM, et al. Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival. Cancer. 2004;101(1):3-27. doi: 10.1002/cncr.20288. [PubMed: 15221985].
  • 12. Ries L AG, Melbert D, Krapcho M. SEER cancer statistics review, 1975-2005. Bethesda, MD; 2008.
  • 13. Boyle P, Langman JS. ABC of colorectal cancer: Epidemiology. BMJ. 2000;321(7264):805-8. doi: 10.1136/bmj.321.7264.805. [PubMed: 11009523]. [PubMed Central: PMC1118620].
  • 14. Mazdak H, Tolou-Ghamari Z. Preliminary study of prevalence for bladder cancer in Isfahan Province, Iran. Arab J Urol. 2018;16(2):206-10. doi: 10.1016/j.aju.2017.11.017. [PubMed: 29892483]. [PubMed Central: PMC5992262].
  • 15. Tolou Ghamari Z. Prevalence of lung cancer in Isfahan province, Iran. J Egypt Natl Canc Inst. 2018;30(2):57-9. doi: 10.1016/j.jnci.2018.03.001. [PubMed: 29691096].
  • 16. Tolou Ghamari Z, Tadayon F, Mazdak H. Prevalence of liver cancer in Isfahan province, Iran. Indonesian J Cancer. 2018;12(2):56-9. doi: 10.33371/ijoc.v12i2.578.
  • 17. Tolou-Ghamari Z. Prevalence of breast cancer in Isfahan province, Iran. Women Health Bull. 2018;5(4). e82678. doi: 10.5812/whb.82678.
  • 18. Tolou-Ghamari Z. Prevalence of skin cancer in Isfahan province, Iran. Jentashapir J Health Res. 2018;9(2). e82743. doi: 10.5812/jjhr.82743.
  • 19. Ghamari ZT. Prevalence of stomach cancer in Isfahan province, Iran. Gulf J Oncolog. 2018;1(28):42-5. doi: 10.5812/whb.82678. [PubMed: 30344133].
  • 20. Kolligs FT. Diagnostics and epidemiology of colorectal cancer. Visc Med. 2016;32(3):158-64. doi: 10.1159/000446488. [PubMed: 27493942]. [PubMed Central: PMC4945785].
  • 21. Rafiemanesh H, Pakzad R, Abedi M, Kor Y, Moludi J, Towhidi F, et al. Colorectal cancer in Iran: Epidemiology and morphology trends. EXCLI J. 2016;15:738-44. doi: 10.17179/excli2016-346. [PubMed: 28337105]. [PubMed Central: PMC5318687].
  • 22. Potter JD, Hunter D. Colorectal cancer: Epidemiology. In: Potter JD LN, editor. Genetics of colorectal cancer. New York: Springer; 2009. p. 5-25. doi: 10.1007/978-0-387-09568-4_1.
  • 23. Meysamie A, Ghaletaki R, Haghazali M, Asgari F, Rashidi A, Khalilzadeh O, et al. Pattern of tobacco use among the Iranian adult population: Results of the national survey of risk factors of non-communicable diseases (SuRFNCD-2007). Tob Control. 2010;19(2):125-8. doi: 10.1136/tc.2009.030759. [PubMed: 20008159]. [PubMed Central: PMC2989156].
  • 24. Tolou-Ghamari Z, Shaygannejad V, Ashtari F. Preliminary study related the incidence of methylprednisolone pulse therapy in patients visited multiple sclerosis clinic located at the Isfahan Kashani Hospital. Int J Prev Med. 2013;4(Suppl 2):S274-8. [PubMed: 23776737]. [PubMed Central: PMC3678231].
  • 25. Shaygannejad V, Tolou-Ghamari Z. What is the Real Fate of Vitamin D in Multiple Sclerosis? Int J Prev Med. 2013;4(Suppl 2):S159-64. [PubMed: 23776718]. [PubMed Central: PMC3678212].
  • 26. Tolou Ghamari Z, Mehavari Habibabadi J, Palizban AA. Evidence-based pharmacotherapy of epilepsy. Arch Neurosci. 2014;2(2). e18468. doi: 10.5812/archneurosci.18468.

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments